Mani, Inc.: what insiders have been doing
This page follows insider dealings at Mani, Inc. as filed with EDINET (Japan FSA), a company from the Health Care sector. Between 26 October 2025 and 26 October 2026, 1 insider published 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Insider buying of Mani, Inc. has been absent for the past year. Filings reach the EDINET (Japan FSA) feed a median of 7 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done.
Across the 3,205 companies tracked on its exchange, the median is 3 filings; at 3 filings, this issuer sits right on that mark.
Source: insider filings from EDINET (Japan FSA). Past trades are no guide to future returns.
Analyst consensus: bullish or bearish?
Analysts rate Mani, Inc. Buy (bullish), based on 7 analysts. Average price target: JP¥1,887.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended August 2025 · cache
- ShareXTKSEDINET:S100YSVO
- ShareXTKSEDINET:S100X6S7
- ShareXTKSEDINET:S100WXJ7
- ShareXTKSEDINET:S100WFLK
- 100.0% of flowShareXTKSEDINET:S100WAZD
- ShareXTKSEDINET:S100V6DR
- 100.0% of flowShareXTKSEDINET:S100RSXG
- ShareXTKSEDINET:S100RBLR
- ShareXTKSEDINET:S100QJFZ
- ShareXTKSEDINET:S100PG8C
- ShareXTKSEDINET:S100N94X
- ShareXTKSEDINET:S100N069
12 of 12 declarations
About Mani, Inc.
マニー株式会社 is a company in the health and pharmaceutical sector, listed on the XTKS market. It specializes in the development and distribution of pharmaceutical products.
